Jardiance

Prime Therapeutics signs outcomes-based contract for Jardiance

Prime Therapeutics signs outcomes-based contract for Jardiance

By

Jardiance treats patients with type 2 diabetes and heart disease, lowering blood sugar and reducing the risk of death from heart disease.